Evidence map›Paper›PMID 34399708›Full record

ArticleBMC cancer2021

Association of Single Nucleotide Polymorphism LEP-R c.668A>G (p.Gln223Arg, rs1137101) of leptin receptor gene with endometrial cancer.

Jan Bieńkiewicz, Hanna Romanowicz, Miłosz Wilczyński, Grzegorz Jabłoński, Anna Stepowicz, Anna Obłękowska, Andrzej Malinowski, Beata Smolarz

Open access · goldAbstract read
In one paragraph

Article in BMC cancer, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 2 pooled it
0.9field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 2 syntheses or guidelines pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Alternative splicing ofJournal of gynecologic oncology · 2023
    Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Jan BieńkiewiczDepartment of Operative Gynecology, Endoscopy and Gynecologic Oncology, Polish Mother's Memorial Hospital-Research Institute, Lodz, Poland. jan.bienkiewicz@iczmp.edu.pl.
Hanna RomanowiczDepartment of Clinical Pathology, Polish Mother's Memorial Hospital - Research Institute, Lodz, Poland.
Miłosz WilczyńskiDepartment of Operative Gynecology, Endoscopy and Gynecologic Oncology, Polish Mother's Memorial Hospital-Research Institute, Lodz, Poland.
Grzegorz JabłońskiDepartment of Operative Gynecology, Endoscopy and Gynecologic Oncology, Polish Mother's Memorial Hospital-Research Institute, Lodz, Poland.
Anna StepowiczDepartment of Obstetrics, Perinatology and Gynecology, Polish Mother's Memorial Hospital-Research Institute, Lodz, Poland.
Anna ObłękowskaDepartment of Operative Gynecology, Endoscopy and Gynecologic Oncology, Polish Mother's Memorial Hospital-Research Institute, Lodz, Poland.
Andrzej MalinowskiDepartment of Operative and Endoscopic Gynecology, Medical University of Lodz, Lodz, Poland.
Beata SmolarzLaboratory of Cancer Genetics, Department of Clinical Pathology, Polish Mother's Memorial Hospital-Research Institute, Lodz, Poland.
Polish Mother’s Memorial Hospital Research Institute · PLMedical University of Lodz · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe aim of this study was to analyze the frequencies of genotypes and alleles of Single Nucleotide Polymorphism (SNP) LEP-R c.668A>G (p.Gln223Arg, rs1137101) of leptin receptor gene and to assess the influence this DNA marker has on endometrial cancer (EC) with respect to total body fat content.

methodsThe study comprised 120 patients treated for endometrial cancer and 90 controls treated for uterine fibroids. In total, 210 patients were included in this research. DNA was isolated from archival post-operative specimens. Polymerase Chain Reaction - Restriction Fragment Length Polymorphism was employed to analyze the SNP.

resultsIn this paper we have demonstrated that heterozygous genotype AG of SNP LEP-R c.668A>G (p.Gln223Arg, rs1137101) is statistically less frequent in women with endometrial cancer (EC) than in controls: 33 versus 57%, respectively. Similarly, this heterozygous genotype is statistically significantly less frequent in obese (BMI > 30) women with EC than in lean controls (BMI < 25): 30 versus 63%, respectively.

conclusionsAG polymorphic variant of SNP LEP-R c.668A>G (p.Gln223Arg, rs1137101) in LEP-R may be considered a protective factor in the development of endometrial cancer.

Indexed as

Genetic Predisposition to DiseasePolymorphism, Single NucleotideBiomarkers, TumorCase-Control StudiesEndometrial NeoplasmsFemaleFollow-Up StudiesGenotypeHumansPrognosisReceptors, LeptinBiomarkers, TumorLEPR protein, humanReceptors, LeptinAdipokinesc.668A>GEndometrial cancerLEP-RLeptinObesityp.Gln223Argrs1137101Single nucleotide polymorphismUterine fibroidsUterine leiomyomas

Identifiers

PMID34399708
PMCPMC8369646
OpenAlexW3111720263

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.